Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 4, 1999, Pages 511-515

  Debets Ossenkopp, Yvette J ^a   Herscheid, Aryanna J ^a   Pot, Raymond G J ^a   Kuipers, Ernst J ^a   Kusters, Johannes G ^a   Vandenbroucke Grauls, Christina M J E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; QUINOLONE DERIVATIVE; TETRACYCLINE; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NONHUMAN;

EID: 0032954246     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.4.511     Document Type: Article

References (14)

1. NIH Consensus Conference. (1994). Helicobacter pylori in peptic ulcer disease. JAMA 272, 65-9.
2. Walsh, J. H. & Peterson, W. L. (1995). The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. New England Journal of Medicine 333, 984-91.
3. Debets-Ossenkopp, Y. J., Sparrius, M., Kusters, J. G., Kolkman, J. J. & Vandenbroucke-Grauls, C. M. J. E. (1996). Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiology Letters 142, 37-42.
4. Megraud, F., Occhialini, A. & Doermann, H. P. (1997). Resistance of Helicobacter pylori to macrolides and nitroimidazole compounds. The current situation. Journal of Physiology and Pharmacology 48, Suppl. 4, 25-38.
5. Xia, H. X., Keane, C. T. & O'Morain, C. A. (1996). A 5-year survey of metronidazole and clarithromycin resistance in clinical isolates of Helicobacter pylori. Gut 39, Suppl. 2, A6.
6. Lopez-Brea, M., Domingo, D., Sanchez, I. & Alarcon, T. (1997). Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain. Journal of Antimicrobial Chemotherapy 40, 279-81.
7. van Zwet, A. A., de Boer, W. A., Schneeberger, P. M., Weel, J., Jansz, A. R. & Thijs, J. C. (1996). Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands. European Journal of Clinical Microbiology and Infectious Diseases 15, 861-4.
8. van der Wouden, E. J., van Zwet, A. A., Vosmaer, G. D. C., Oom, J. A. J., de Jong, A. & Kleibeuker, J. H. (1997). Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in The Netherlands. Emerging Infectious Diseases 3, 385-9.
9. Midolo, P. D., Korman, M. G., Turnidge, J. D. & Lambert, J. R. (1996). Helicobacter pylori resistance to tetracycline. Lancet 347, 1194-5.
10. 14C] CP-99,219 into gastric tissue of Long-Evans rats and Swiss-Webster mice following intravenous administration. In Abstracts of the Seventh European Congress of Clinical Microbiology and Infectious Diseases, Vienna, 26-30 March 1995, Abstract 745 p.144.
11. Girard, A. E., Cimochowski, C. R., Girard, D., Gootz, T. D. & Brighty, K. E. (1995). In vitro and in vivo activities of CP-99,219 against Helicobacter. Abstracts of the Seventh European Congress of Clinical Microbiology and Infectious Diseases, Vienna, 26-30 March 1995, Abstract 739 p. 143.
12. Glupczynski, Y., Labbé, M., Hansen, W., Crokaert, F. & Yourassowsky, E. (1991). Evaluation of the Etest for quantitative antimicrobial susceptibility testing of Helicobacter pylori. Journal of Clinical Microbiology 29, 2072-5.
13. Versalovic, J., Shortridge, D., Kibler, K., Griffy, M. V., Beyer, J., Flamm, R. K. et al. (1996). Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy 40, 477-80.
14. Buckley, M. J., Xia, H. X., Hyde, D. M., Keane, C. T. & O'Morain, C. A. (1997). Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. Digestive Diseases and Sciences 42, 2111-5.